Zobrazeno 1 - 10
of 3 688
pro vyhledávání: '"Rio JA"'
Autor:
Mª. P. Pascual Mayoral
Publikováno v:
Antigüedad y Cristianismo, Iss 16 (1999)
El artículo describe muy brevemente los yacimientos en los que se encuentran los «columbarios » a lo largo y ancho de la geografía de La Rioja. Lleva la cartografía del conjunto y de cada uno de ellos. Se hacen algunas anotaciones arqueológicas
Externí odkaz:
https://doaj.org/article/860d4d37ddf547ff9c03a6f0ec67da84
Autor:
Rio JA; Department of Ophthalmology, Leitão Guerra - Oftalmologia, Salvador, Brazil., Barbosa GCS; Department of Ophthalmology, Suel Abujamra Institute, São Paulo, Brazil., Guerra RLL; Department of Ophthalmology, Leitão Guerra - Oftalmologia, Salvador, Brazil.
Publikováno v:
Oman journal of ophthalmology [Oman J Ophthalmol] 2024 Feb 21; Vol. 17 (1), pp. 137-139. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Andrés-Benito P; Department of Pathology and Experimental Therapeutics, University of Barcelona, CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, Bellvitge University Hospital/Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. Electronic address: pandres@idibell.cat., Carmona M; Department of Pathology and Experimental Therapeutics, University of Barcelona, CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, Bellvitge University Hospital/Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. Electronic address: mcarmona@idibell.cat., Pirla MJ; Department of Pathology and Experimental Therapeutics, University of Barcelona, CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, Bellvitge University Hospital/Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. Electronic address: mjordanpirla@gmail.com., Torrejón-Escribano B; Advanced Light Microscopy Unit (Campus de Bellvitge), Scientific and Technical Facility (CCiTUB), University of Barcelona, Hospitalet de Llobregat, Spain. Electronic address: torrejonbenja@ub.edu., Del Rio JA; Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Barcelona Institute for Science and Technology, Science Park Barcelona (PCB), Barcelona, Spain; Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Spain. Electronic address: jadelrio@ibecbarcelona.eu., Ferrer I; Department of Pathology and Experimental Therapeutics, University of Barcelona, CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, Bellvitge University Hospital/Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. Electronic address: 8082ifa@gmail.com.
Publikováno v:
Neuroscience [Neuroscience] 2023 May 10; Vol. 518, pp. 119-140. Date of Electronic Publication: 2021 Oct 30.
Autor:
Hernández F; Centro de Biología Molecular 'Severo Ochoa' (CBMSO) CSIC/UAM, Madrid, Spain., Ferrer I; Department of Pathology and Experimental Therapeutics, University of Barcelona, Bellvitge, University Hospital-IDIBELL, Hospitalet de Llobregat, Spain; Department of Cell Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, 08028 Barcelona, Spain., Pérez M; Departamento de Anatomía Histología y Neurociencia, Facultad de Medicina UAM, Madrid, Spain., Zabala JC; Department of Molecular Biology, Facultad de Medicina, Universidad de Cantabria, Santander 39005 Spain., Del Rio JA; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain; Department of Cell Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, 08028 Barcelona, Spain; Institute of Neuroscience, University of Barcelona, 08028 Barcelona, Spain., Avila J; Centro de Biología Molecular 'Severo Ochoa' (CBMSO) CSIC/UAM, Madrid, Spain; Networking Research Centre on Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain. Electronic address: javila@cbm.csic.es.
Publikováno v:
Neuroscience [Neuroscience] 2023 May 10; Vol. 518, pp. 64-69. Date of Electronic Publication: 2022 May 04.
Autor:
Martinez-Torres S; Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.; Department of Cell Biology, Physiology and Immunology, University of Barcelona, Barcelona, Spain.; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.; Institute of Neuroscience, University of Barcelona, Barcelona, Spain., Mesquida-Veny F; Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.; Department of Cell Biology, Physiology and Immunology, University of Barcelona, Barcelona, Spain.; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.; Institute of Neuroscience, University of Barcelona, Barcelona, Spain., Del Rio JA; Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.; Department of Cell Biology, Physiology and Immunology, University of Barcelona, Barcelona, Spain.; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.; Institute of Neuroscience, University of Barcelona, Barcelona, Spain., Hervera A; Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.; Department of Cell Biology, Physiology and Immunology, University of Barcelona, Barcelona, Spain.; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.; Institute of Neuroscience, University of Barcelona, Barcelona, Spain.; Clinical Neuroimmunology Group, Vall Hebron Research Institute (VHIR), Barcelona, Spain.; Multiple Sclerosis Centre of Catalonia (CEM-CAT), Barcelona, Spain.
Publikováno v:
IScience [iScience] 2023 May 05; Vol. 26 (6), pp. 106814. Date of Electronic Publication: 2023 May 05 (Print Publication: 2023).
Peripheral CB1 receptor blockade acts as a memory enhancer through an adrenergic-dependent mechanism
Autor:
Ruiz-Ortega Ja, Lorena Galera-López, A. Ortega-Alvaro, Floortje Remmers, Emma Muñoz-Moreno, Andrés Ozaita, Hervera Abad A, del Rio Ja, Bergada-Martinez A, Ortega J, J. Javier Meana, Beat Lutz, Martinez-Torres S, Rafael Maldonado, Guadalupe Soria
Peripheral inputs to the brain continuously shape its function and can influence the formation of non-emotional memory, but the underlying mechanisms have not been fully understood. Cannabinoid type-1 receptors (CB1R), widely distributed in the organ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a0c384415e7dbc3e8298cca1dfb4318
https://doi.org/10.1101/2021.06.16.448227
https://doi.org/10.1101/2021.06.16.448227
Autor:
del Rio Ja, Brewer Mk, Jordi Duran, Prat N, López-Soldado I, Pellegrini P, Varea O, Joan J. Guinovart, Guitart A, Arnau Hervera, Aguilera M
BackgroundLafora disease (LD) is a fatal childhood-onset dementia characterized by the extensive accumulation of glycogen aggregates—the so-called Lafora Bodies (LBs)—in several organs. The accumulation of LBs in the brain underlies the neurologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba4310a229fb376b919f0cedb9172e6c
https://doi.org/10.1101/2021.06.03.446965
https://doi.org/10.1101/2021.06.03.446965
Autor:
Andrés-Benito P; Neurologic Diseases and Neurogenetics Group, Bellvitge Institute for Biomedical Research (IDIBELL), 08907 L'Hospitalet de Llobregat, Barcelona, Spain.; CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, 08907 L'Hospitalet de Llobregat, Barcelona, Spain., Flores Á; Neuropharmacology & Pain Group, Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, 08907 L'Hospitalet de Llobregat, Barcelona, Spain., Busquet-Areny S; Neuropathology Group, Bellvitge Institute for Biomedical Research (IDIBELL), 08907 L'Hospitalet de Llobregat, Barcelona, Spain., Carmona M; CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.; Neuropathology Group, Bellvitge Institute for Biomedical Research (IDIBELL), 08907 L'Hospitalet de Llobregat, Barcelona, Spain., Ausín K; Clinical Neuroproteomics Unit, Proteomics Platform, Proteored-ISCIII, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), diSNA, 31008 Pamplona, Navarra, Spain., Cartas-Cejudo P; Clinical Neuroproteomics Unit, Proteomics Platform, Proteored-ISCIII, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), diSNA, 31008 Pamplona, Navarra, Spain., Lachén-Montes M; Clinical Neuroproteomics Unit, Proteomics Platform, Proteored-ISCIII, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), diSNA, 31008 Pamplona, Navarra, Spain., Del Rio JA; CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.; Molecular and Cellular Neurobiotechnology Group, Institute of Bioengineering of Catalonia (IBEC), Barcelona Institute for Science and Technology, Science Park Barcelona (PCB), 08028 Barcelona, Barcelona, Spain., Fernández-Irigoyen J; Clinical Neuroproteomics Unit, Proteomics Platform, Proteored-ISCIII, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), diSNA, 31008 Pamplona, Navarra, Spain., Santamaría E; Clinical Neuroproteomics Unit, Proteomics Platform, Proteored-ISCIII, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), diSNA, 31008 Pamplona, Navarra, Spain., Ferrer I; CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.; Neuropathology Group, Bellvitge Institute for Biomedical Research (IDIBELL), 08907 L'Hospitalet de Llobregat, Barcelona, Spain.; Department of Pathology and Experimental Therapeutics, University of Barcelona, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.; Emeritus Researcher, Bellvitge Biomedical Research Institute (IDIBELL), Emeritus Professor, University of Barcelona, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 31; Vol. 24 (7). Date of Electronic Publication: 2023 Mar 31.
Autor:
Tonelli M; Department of Pharmacy, University of Genoa, 16132, Genoa, Italy. Electronic address: michele.tonelli@unige.it., Catto M; Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, 70125, Bari, Italy. Electronic address: marco.catto@uniba.it., Sabaté R; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028, Barcelona, Spain. Electronic address: rsabate@ub.edu., Francesconi V; Department of Pharmacy, University of Genoa, 16132, Genoa, Italy., Laurini E; Molecular Biology and Nanotechnology Laboratory (MolBNL@UniTS), Department of Engineering and Architecture, University of Trieste, 34127, Trieste, Italy., Pricl S; Molecular Biology and Nanotechnology Laboratory (MolBNL@UniTS), Department of Engineering and Architecture, University of Trieste, 34127, Trieste, Italy; Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 90-236, Lodz, Poland., Pisani L; Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, 70125, Bari, Italy., Miniero DV; Department of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, 70125, Bari, Italy., Liuzzi GM; Department of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, 70125, Bari, Italy., Gatta E; Department of Physics, University of Genoa, 16146, Genoa, Italy., Relini A; Department of Physics, University of Genoa, 16146, Genoa, Italy., Gavín R; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, 08028, Barcelona, Spain; Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, 08028, Barcelona, Spain; Institute of Neuroscience, University of Barcelona, 08028, Barcelona, Spain., Del Rio JA; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, 08028, Barcelona, Spain; Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, 08028, Barcelona, Spain; Institute of Neuroscience, University of Barcelona, 08028, Barcelona, Spain., Sparatore F; Department of Pharmacy, University of Genoa, 16132, Genoa, Italy., Carotti A; Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, 70125, Bari, Italy.
Publikováno v:
European journal of medicinal chemistry [Eur J Med Chem] 2023 Mar 15; Vol. 250, pp. 115169. Date of Electronic Publication: 2023 Feb 02.